Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (pcp) binding site: tentative evidence for pcp recognition sites not coupled to n-methyl-d-aspartate (nmda) receptors
Authors:
- T.S. RaoTRT.S. Rao
- H.S. KimHKH.S. Kim
- J. LehmannJLJ. Lehmann
- L.L. MartinLML.L. Martin
- P.L. WoodPWP.L. Wood
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 29 (3) , 225-230
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine releaseLife Sciences, 1989
- Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis StudyJournal of Neurochemistry, 1988
- The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of ?-aspartic acid into the nucleus accumbensNeuropharmacology, 1988
- A comparison of PCP-like compounds for NMDA antagonism in two modelsLife Sciences, 1988
- Classification and nomenclature of phencyclidine and sigma receptor sitesTrends in Neurosciences, 1987
- Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists; evidence for possible allosteric coupling of NMDA and PCP receptorsCanadian Journal of Physiology and Pharmacology, 1987
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- Antagonists of excitatory amino acids and cyclic guanosine monophosphate in cerebellumNeuropharmacology, 1982
- A selected ion monitoring assay for dopamine and its metabolites using negative chemical ionizationJournal of Mass Spectrometry, 1982
- BW234U,(cis-9-[3–(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agentJournal of Pharmacy and Pharmacology, 1982